Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Clinical Effectiveness of Training for Awareness Resilience and Action Online Compared to Standard Treatment for Adolescents and Young Adults With Depression: Study Protocol and Analysis Plan for a Pragmatic, Multi-Center Randomized Controlled Superiority Trial
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Barn- och ungdomspsykiatri.ORCID-id: 0000-0003-0496-7158
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Barn- och ungdomspsykiatri.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Barn- och ungdomspsykiatri.ORCID-id: 0000-0003-0487-5552
Visa övriga samt affilieringar
2021 (Engelska)Ingår i: Frontiers in Psychiatry, E-ISSN 1664-0640, Vol. 12, artikel-id 674583Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Depression in adolescents and young adults is an increasing global health concern. Available treatments are not sufficiently effective and relapse rates remain high. The novel group-treatment program “Training for Awareness, Resilience and Action” (TARA) targets specific mechanisms based on neuroscientific findings in adolescent depression. TARA is framed within the National Institute of Mental Health's Research Domain Criteria and has documented feasibility and preliminary efficacy in the treatment of adolescent depression. Since neurodevelopment continues well into the mid-twenties, age-adapted treatments are warranted also for young adults. Patients 15–22 years old, with either major depressive disorder (MDD) or persistent depressive disorder (PDD) according to the DSM-IV/5 or a rating >40 on the clinician rating scale Children's Depression Rating Scale—Revised (CDRS-R), will be recruited from specialized Child and Adolescent Psychiatry and local Youth-Clinics and randomized to either TARA or standard treatment, including but not limited to antidepressant medication and/or psychotherapy. Outcome measures will be obtained before randomization (T0), after 3 months of treatment (T1) and at 6-months- (T2) and 24-months- (T3) follow-up. Additionally, dose-response measures will be obtained weekly in the TARA-arm and measures for mediation-analysis will be obtained halfway through treatment (T0.5). Primary outcome measure is Reynolds Adolescent Depression Scale (RADS-2) score at T1. Secondary outcome measures include RADS-2 score at T2, Multidimensional Anxiety Scale for Children at T1 and T2, and CDRS-R at T1. Additional outcome measures include self-report measures of depression-associated symptoms, systemic bio-indicators of depression from blood and hair, heartrate variability, brain magnetic resonance imaging, as well as three-axial accelerometry for sleep-objectivization. Qualitative data will be gathered to reach a more comprehensive understanding of the factors affecting adolescents and young adults with depression and the extent to which the different treatments address these factors. In summary, this article describes the design, methods and statistical analysis plan for pragmatically evaluating the clinical effectiveness of TARA. This will be the first RCT to examine the effects of TARA compared to standard treatment for adolescents and young adults with MDD or PDD. We argue that this study will extend the current knowledgebase regarding the treatment of depression.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2021. Vol. 12, artikel-id 674583
Nyckelord [en]
adolescent depression, antidepressant drugs, biomarkers, psychotherapy, randomization, yoga, young adults
Nationell ämneskategori
Psykiatri
Forskningsämne
psykiatri
Identifikatorer
URN: urn:nbn:se:umu:diva-189121DOI: 10.3389/fpsyt.2021.674583ISI: 000713179300001PubMedID: 34707516Scopus ID: 2-s2.0-85117953482OAI: oai:DiVA.org:umu-189121DiVA, id: diva2:1610974
Forskningsfinansiär
Kempestiftelserna, LVNFOU933598Läkemedelsverket, SLS-935854Tillgänglig från: 2021-11-12 Skapad: 2021-11-12 Senast uppdaterad: 2024-01-17Bibliografiskt granskad

Open Access i DiVA

fulltext(954 kB)136 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 954 kBChecksumma SHA-512
5a41e16e9ab02bd991e984588bc117835b9c5ac022276623b470609fb466d34b0b7cbbbee7bec95240c2164f8f563b89c1f777db609a46f2317221a59bb34a4d
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Ekbäck, ErikGranåsen, GabrielSvärling, RachelBlomqvist, IdaHenje Blom, Eva

Sök vidare i DiVA

Av författaren/redaktören
Ekbäck, ErikGranåsen, GabrielSvärling, RachelBlomqvist, IdaHenje Blom, Eva
Av organisationen
Barn- och ungdomspsykiatriInstitutionen för folkhälsa och klinisk medicin
I samma tidskrift
Frontiers in Psychiatry
Psykiatri

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 136 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 308 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf